DerrickSHaslemMD

Oncology • Saint George, UT

Physician

Join to view full profile

Dr. Haslem is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Haslem's full profile

Already have an account?

Office
600 S Medical Center Dr
Saint George, UT 84790
Phone+1 435-251-4900
Is this information wrong?

Education & Training

University of Utah HealthFellowship, Hematology and Medical Oncology, 2007 - 2009
University of Utah HealthResidency, Internal Medicine, 2004 - 2007
University of Utah School of MedicineClass of 2004

Certifications & Licensure

AZ State Medical License 2020 - 2026
UT State Medical License 2005 - 2026
NV State Medical License 2020 - 2025
CO State Medical License 2020 - 2025
ID State Medical License 2017 - 2025
WY State Medical License 2018 - 2024
MT State Medical License 2020 - 2024
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

3 citations
The Development of an Infrastructure to Facilitate the Use of Whole Genome Sequencing for Population Health.
Nephi A Walton, Brent Hafen, Sara Graceffo, Nykole Sutherland, Melanie Emmerson, Rachel Palmquist, Christine M Formea, Maricel Purcell, Bret Heale, Matthew A Brown, Ch...> ;Journal of Personalized Medicine. 2022 Nov 8
3 citations
Germline variants of ATG7 in familial cholangiocarcinoma alter autophagy and p62.
Stephanie U Greer, Jiamin Chen, Margret H Ogmundsdottir, Carlos Ayala, Billy T Lau, Richard Glenn C Delacruz, Imelda T Sandoval, Sigrun Kristjansdottir, David A Jones,...> ;Scientific Reports. 2022 Jun 20
17 citations
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA).
Ivan O Rosas, Norbert Bräu, Michael Waters, Ronaldo C Go, Atul Malhotra, Bradley D Hunter, Sanjay Bhagani, Daniel Skiest, Sinisa Savic, Ivor S Douglas, Julia Garcia-Di...> ;Eclinicalmedicine. 2022 May 1
3 citations
Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs
Adrienne T Perkins, Derrick S. Haslem, Jessica Goldsberry, Katherine Shortt, Laura Sittig, Sharanya Raghunath, Christopher Giauque, Shawnee Snow, Gail Fulde, Bryce Mou...> ;Cancers. 2021 Nov 10
18 citations
Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial.
, , , , , , , , , , , , , , , , , , , , , > ;Critical Care Medicine. 2021 Oct 12
73 citations
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) S...
Ajjai Alva, Pam K. Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Damien Hansra, Carmen Julia Calfa, Maged F. Khalil, Eugene R Ahn, Timothy L. Cannon, Pamela A. Crille...> ;Journal of Clinical Oncology. 2021 Apr 12
30 citations
Telehealth Is a Sustainable Population Health Strategy to Lower Costs and Increase Quality of Health Care in Rural Utah.
Ramya Thota, David Gill, Jamie Brant, Timothy J. Yeatman, Derrick S. Haslem> ;JCO Oncology Practice. 2020 May 28
4 citations
Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer
Li C. Xia, Paul Van Hummelen, Matthew Kubit, Hojoon Lee, John Bell, Susan M. Grimes, Christina Wood-Bouwens, Stephanie U. Greer, Tyler Barker, Derrick S. Haslem, James...> ;Scientific Reports. 2020 Mar 19
10 citations
Therapeutic Monitoring of Circulating DNA Mutations in Metastatic Cancer with Personalized Digital PCR.
Christina Wood-Bouwens, Derrick S. Haslem, Bryce Moulton, Alison Almeda, Hojoon Lee, Gregory M. Heestand, Lincoln Nadauld, Hanlee P. Ji> ;The Journal of Molecular Diagnostics. 2020 Feb 1
33 citations
Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs.
Derrick S. Haslem, Ingo Chakravarty, Gail Fulde, Heather Gilbert, Karen Lin, James M. Ford, Lincoln Nadauld> ;Oncotarget. 2018 Feb 2
6 citations
Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2-Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab...
Derrick S. Haslem, Hanlee P. Ji, James M. Ford, Lincoln Nadauld> ;JCO Precision Oncology. 2017 Jun 27
54 citations
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs
, , , , , , , , , , , , , , , > ;Journal of Oncology Practice. 2017 Feb 1
32 citations
Success rate of direct percutaneous endoscopic jejunostomy in patients who are obese.
Scott H. Mackenzie, Derrick Haslem, Kristen Hilden, Kristen Thomas, John C. Fang> ;Gastrointestinal Endoscopy. 2008 Feb 1
66 citations
Video capsule endoscopy compared with standard endoscopy for the evaluation of small-bowel polyps in persons with familial adenomatous polyposis (with video).
Robert F. Wong, Ashok K. Tuteja, Derrick Haslem, Lisa Pappas, Aniko Szabo, Maydeen Ogara, James A. DiSario> ;Gastrointestinal Endoscopy. 2006 Oct 1
Join now to see all

Press Mentions

‘The Future of Cancer Care Really Is Bright’: Virtual Jubilee of Trees Benefits Cancer Care, HerediGene StudyNovember 18th, 2020
Jubilee of Trees Goes Virtual, Benefits Cancer Care at Dixie Regional Medical CenterNovember 13th, 2020
Intermountain Cancer Center to Open in St. GeorgeJanuary 3rd, 2019
Join now to see all